Hemarus Therapeutics Limited - Company Profile

It is a life sciences public limited company based in Shaikpet, Telangana, India, established in 2003.
2003 Shaikpet, Telangana, India Active
Last Updated:
Access Report
About Hemarus Therapeutics Limited

Hemarus Therapeutics Limited, a active public limited company, was established on 16 September 2003 in Shaikpet, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U74220TG2003PLC041698. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹1.00 M.

Formerly known as Hemarus Therapeutics Private Limited, Credence Clinical Research Private Limited. It upholds a compliant status. Employing 68 professional, Its leadership includes Kavali Dharmendra (Director), Balaraju Jittaboina (Director), Santosh Kumar Surana (Director). Past directors included Pradeep Vasu, Hemang Harish Raja, Seema. It holds no open charges and ₹75.40 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8-2-293/82/Jiii/359, Plot No.359-Iii, Raod No.80, Jubilee Hills, Shaikpet, Telangana, 500033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74220TG2003PLC041698

  • Registration Number

    041698

  • Incorporation Date

    16 September 2003

  • Authorized Capital

    ₹40.00 Cr

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 1.00 M
  • Company Age 22 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 75.40 Cr
  • Revenue Growth **** -84.64%
  • Profit Growth **** -275.80%
  • Ebitda **** -716.81%
  • Net Worth -73.64%
  • Total Assets -87.88%
Company report

Hemarus Therapeutics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hemarus Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Hemarus Therapeutics Limited?
Current Directors
Name Designation Appointment Date Status
Kavali Dharmendra Director 25 Oct 2024 Current
Balaraju Jittaboina Director 25 Oct 2024 Current
Santosh Kumar Surana Director 25 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 27 May 2016 Past
Pramod Abcsdd Director 15 Jan 2016 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 10 May 2019 Past
Pramod Abcsdd Irp/Rp/Liquidator 21 Dec 2024 Past
Pramod Abcsdd Director 21 Feb 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hemarus Therapeutics.

Hemarus Therapeutics Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 84.64% decrease. The company also saw a substantial fall in profitability, with a 275.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.64%.

Hemarus Therapeutics revenue growth over time
Hemarus Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -84.64%
*******
*******
*******
*******
Revenue from Operations
*******
 -72.19%
*******
*******
*******
*******
Total Assets
*******
 -87.88%
*******
*******
*******
*******
Profit or Loss
*******
 -275.80%
*******
*******
*******
*******
Net Worth
*******
 -73.64%
*******
*******
*******
*******
EBITDA
*******
 -716.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hemarus Therapeutics?

In 2022, Hemarus Therapeutics had a promoter holding of 90.54% and a public holding of 9.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹754,000,000.00

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 66.68 Cr
  • Andhra Pradesh State Financial Corporation : 8.72 Cr
Latest Charge Details
Date Lender Amount Status
26 Feb 2011 Indian Overseas Bank ₹66.68 Cr Satisfied
10 Aug 2004 Andhra Pradesh State Financial Corporation ₹8.72 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Hemarus Therapeutics?

Hemarus Therapeutics has a workforce of 68 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemarus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemarus Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hemarus Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Hemarus Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Hemarus Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Kavali Dharmendra was appointed as a Director was appointed as a Director on 25 Oct 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Balaraju Jittaboina was appointed as a Director was appointed as a Director on 25 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Director Appointment

    Santosh Kumar Surana was appointed as a Director was appointed as a Director on 25 Oct 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 26 Feb 2011 via Charge ID 10280683 with Indian Overseas Bank was fully satisfied on 27 Jan 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hemarus Therapeutics Limited?

The CIN of Hemarus Therapeutics Limited is U74220TG2003PLC041698.

Where is Hemarus Therapeutics Limited headquartered?

Hemarus Therapeutics Limited is headquartered at 8-2-293/82/Jiii/359, Plot No.359-Iii, Raod No.80, Jubilee Hills, Shaikpet, Telangana, 500033.

When was Hemarus Therapeutics Limited incorporated?

Hemarus Therapeutics Limited was incorporated on 16 September 2003.

Who are the current directors of Hemarus Therapeutics Limited?

The current directors of Hemarus Therapeutics Limited are

What is the primary industry of Hemarus Therapeutics Limited?

The primary industry of Hemarus Therapeutics Limited is Manufacturing.

Is Hemarus Therapeutics Limited a listed company?

Hemarus Therapeutics Limited is unlisted.

What is the capital structure of Hemarus Therapeutics Limited?

The authorized capital of Hemarus Therapeutics Limited is ₹40.00 Cr, and the paid-up capital is ₹1.00 M.

What is the compliance status of Hemarus Therapeutics Limited?

The compliance status of Hemarus Therapeutics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available